Coronary vasoconstrictive effects of neuropeptide Y and their modulation by the ATP-sensitive potassium channel in anesthetized dogs
E Tanaka,
H Mori,
M Chujo,
A Yamakawa,
MU Mohammed,
Y Shinozaki,
K Tobita,
T Sekka,
K Ito,
and
H Nakazawa
Department of Physiology, Tokai University School of Medicine, Isehara, Japan.
OBJECTIVES: This study examined the coronary vasoconstrictive action of endogenous neuropeptide Y (NPY) during sympathetic nerve stimulation and its modulation by the adenosine triphosphate (ATP)-sensitive potassium (KATP) channel in vivo. BACKGROUND: Exogenous NPY was characterized by its potent vasoconstrictive effect. However, endogenous NPY has failed to show any vasoconstrictive activity in vivo. METHODS: We studied 70 anesthetized dogs with vagotomy under beta-adrenergic blockade. Ansae subclaviae stimulation and intracoronary administration of the neurotransmitters (NPY and norepinephrine) were done with or without alpha-adrenergic blockade, NPY antagonist BIBP3226 or KATP channel acting agents. We measured coronary vascular resistance (CVR) and the neurotransmitter levels in systemic arteries and the great cardiac vein, and the amount of overflow (venoarterial difference times myocardial blood flow). RESULTS: During nerve stimulation, NPY levels correlated significantly with CVR at the highest r value (r = 0.850, p < 0.0001) obtained for the venous level under alpha-blockade, but norepinephrine showed no correlation. Treatment with BIBP3226 abolished the correlation between NPY level and CVR under alpha-blockade. Without alpha-blockade, norepinephrine levels correlated significantly with CVR; however, NPY showed no correlation. The amount of NPY overflow during the stimulation was nearly 1,000-fold lower than norepinephrine overflow. Exogenous NPY had a 100-fold more potent coronary vasoconstrictive action than that of norepinephrine. The KATP channel antagonist glibenclamide enhanced vasoconstriction of NPY, and the agonist pinacidil suppressed it with a predominant effect in the subepicardial region. CONCLUSIONS: During sympathetic nerve stimulation, the vasoconstrictive actions of NPY are masked by norepinephrine under intact alpha-adrenoceptor conditions, manifest during alpha-blockade and modulated by KATP channel activity.
This article has been cited by other articles:
|
|
|
|
 
M. Yazici, S. Demircan, K. Durna, and M. Sahin
The Role of Adrenergic Activity in Slow Coronary Flow and Its Relationship to TIMI Frame Count
Angiology,
September 1, 2007;
58(4):
393 - 400.
[Abstract]
[PDF]
|
|
|
|
|
|
|
N. Fernandez, L. Monge, A. L. Garcia-Villalon, and G. Dieguez
Coronary reactive hyperaemia and arterial pressure in anaesthetized goats
Exp Physiol,
September 1, 2006;
91(5):
915 - 923.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Kakkar, B. Ye, D. A. Stoller, M. Smelley, N.-Q. Shi, K. Galles, M. Hadhazy, J. C. Makielski, and E. M. McNally
Spontaneous Coronary Vasospasm in KATP Mutant Mice Arises From a Smooth Muscle-Extrinsic Process
Circ. Res.,
March 17, 2006;
98(5):
682 - 689.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Gullestad, T. Bjuro, L. Aaberge, T. Apelland, R. Skardal, E. Kjekshus, M. Nordlander, B. Ablad, and J. Pernow
The effect of a neuropeptide Y Y1 receptor antagonist in patients with angina pectoris
Eur. Heart J.,
June 2, 2003;
24(12):
1120 - 1127.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Tanaka, N. Hattan, K. Ando, H. Ueno, Y. Sugio, M. U. Mohammed, S. A. Voltchikhina, and H. Mori
Amelioration of microvascular myocardial ischemia by gene transfer of vascular endothelial growth factor in rabbits
J. Thorac. Cardiovasc. Surg.,
October 1, 2000;
120(4):
720 - 728.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Gullestad, B. Jorgensen, T. Bjuro, J. Pernow, J. M. Lundberg, C.-D. Dota, C. Hall, S. Simonsen, and B. Ablad
Postexercise Ischemia Is Associated With Increased Neuropeptide Y in Patients With Coronary Artery Disease
Circulation,
August 29, 2000;
102(9):
987 - 993.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
